Bloomberg Law
June 4, 2020, 6:50 PM

Lancet Withdraws Study on Trump-Touted Malaria Drug

Linly Lin
Linly Lin
Bloomberg News

Three authors retracted their Lancet paper on using hydroxychloroquine as possible treatment of Covid-19.

  • The original paper was titled “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis”

To contact the reporter on this story:
Linly Lin in San Francisco at

To contact the editor responsible for this story:
Chakradhar Adusumilli at

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.